The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Spatiotemporal T790M heterogeneity in individual patients with non-small cell lung cancer (NSCLC) after acquired resistance to EGFR-tyrosine kinase inhibitor (TKI).
Akito Hata
No relevant relationships to disclose
Nobuyuki Katakami
No relevant relationships to disclose
Hiroshige Yoshioka
No relevant relationships to disclose
Katsuhiro Masago
No relevant relationships to disclose
Shiro Fujita
No relevant relationships to disclose
Yukihiro Imai
No relevant relationships to disclose
Keisuke Tomii
No relevant relationships to disclose
Akihiro Nishiyama
No relevant relationships to disclose
Tadashi Ishida
No relevant relationships to disclose